SUCLA2 gene mutant and its application
A technology of mutants and β subunits, applied in the direction of recombinant DNA technology, DNA/RNA fragments, bioreactor/fermenter combination, etc., can solve problems such as depletion of mitochondrial DNA, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Example 1 Whole Exome Sequencing Determination of Disease-causing Genes and Mutation Sites
[0049] 1. Sample collection:
[0050] The inventor collected a pedigree of consanguineous marriage in Italy, the parents were married to cousins, the parents were normal, and the two daughters were sick:
[0051] The main clinical manifestations of the first progenitor (PI) were: no abnormalities were found during pregnancy and puerperium. At 1 month of age, myasthenia, growth retardation, slower weight gain, and frequent vomiting occurred. When he was 8 months old, the neurological examination showed that the cranial nerve examination was normal and the visual examination was good; however, the proximal trunk muscles were weak, the movement was slow, and the tendon reflexes were hyperreflexia; he had difficulty swallowing, and nasal feeding was started. Biochemical examination showed: elevated levels of lactate (3057 μmol / l, 193 μmol / l) and pyruvate (2262 μmol / l, 144 μmol / l) ...
Embodiment 2
[0070] Example 2 Sanger method sequencing verification (in-family, out-of-family, sporadic and other sample verification)
[0071] The peripheral blood of patients PI (obtained and preserved in 2011) and PII and their parents in the family were collected, and the genomic DNA in the peripheral blood leukocytes was extracted by the conventional phenol-chloroform method, and the DNA content was measured by a spectrophotometer. Concentration and purity, the OD260 / OD280 of the genomic DNA of each sample obtained is between 1.7-2.0, the concentration is not less than 200ng / μl, and the total amount is not less than 30μg.
[0072] Then, 2 patients (PI and PII) in the family and 2 normal people in the family (the parents of the patients, neither of whom had the disease) were tested, and primers were designed for the sequence between exons 3 and 4 of the SUCLA2 gene , through PCR amplification, product purification, and sequencing to obtain the sequence of the SUCLA2 gene, and to verify...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com